NO20085182L - Treatment of tumors in pediatric patients with antagonists to epidermal growth factor receptor - Google Patents
Treatment of tumors in pediatric patients with antagonists to epidermal growth factor receptorInfo
- Publication number
- NO20085182L NO20085182L NO20085182A NO20085182A NO20085182L NO 20085182 L NO20085182 L NO 20085182L NO 20085182 A NO20085182 A NO 20085182A NO 20085182 A NO20085182 A NO 20085182A NO 20085182 L NO20085182 L NO 20085182L
- Authority
- NO
- Norway
- Prior art keywords
- tumors
- treatment
- antagonists
- growth factor
- factor receptor
- Prior art date
Links
- 102000001301 EGF receptor Human genes 0.000 title 1
- 108060006698 EGF receptor Proteins 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 208000012191 childhood neoplasm Diseases 0.000 abstract 2
- 229940122558 EGFR antagonist Drugs 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Sammendrag Kombinasjonsterapeutiske fremgangsmåter for å behandle pediatriske tumorer ved administrering av en EGFR-antagonist og et kjemoterapeutisk middel er beskrevet. Fremgangsmåtene inkluderer også behandling av gjenstridige, pediatriske tumorer.Summary Combination therapeutic methods for treating pediatric tumors by administration of an EGFR antagonist and a chemotherapeutic agent are described. The procedures also include treatment of stubborn pediatric tumors.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83348706P | 2006-07-27 | 2006-07-27 | |
| PCT/US2007/074448 WO2008014386A2 (en) | 2006-07-27 | 2007-07-26 | Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20085182L true NO20085182L (en) | 2009-04-24 |
Family
ID=38982334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20085182A NO20085182L (en) | 2006-07-27 | 2008-12-11 | Treatment of tumors in pediatric patients with antagonists to epidermal growth factor receptor |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP2043688A4 (en) |
| JP (1) | JP2009544736A (en) |
| KR (1) | KR20090033841A (en) |
| CN (1) | CN101484186A (en) |
| AU (1) | AU2007279261A1 (en) |
| BR (1) | BRPI0712368A2 (en) |
| CA (1) | CA2654911A1 (en) |
| CR (1) | CR10486A (en) |
| EA (1) | EA200870603A1 (en) |
| EC (1) | ECSP089011A (en) |
| MX (1) | MX2008016187A (en) |
| NO (1) | NO20085182L (en) |
| TN (1) | TNSN08512A1 (en) |
| WO (1) | WO2008014386A2 (en) |
| ZA (1) | ZA200810600B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210148228A (en) * | 2019-03-27 | 2021-12-07 | 내셔날 리서치 카운실 오브 캐나다 | Anti-EGFRvIII antibodies and antigen-binding fragments thereof |
-
2007
- 2007-07-26 MX MX2008016187A patent/MX2008016187A/en not_active Application Discontinuation
- 2007-07-26 JP JP2009522001A patent/JP2009544736A/en not_active Withdrawn
- 2007-07-26 EP EP07813400A patent/EP2043688A4/en not_active Withdrawn
- 2007-07-26 CA CA002654911A patent/CA2654911A1/en not_active Abandoned
- 2007-07-26 KR KR1020087031606A patent/KR20090033841A/en not_active Withdrawn
- 2007-07-26 BR BRPI0712368-0A patent/BRPI0712368A2/en not_active Application Discontinuation
- 2007-07-26 EA EA200870603A patent/EA200870603A1/en unknown
- 2007-07-26 AU AU2007279261A patent/AU2007279261A1/en not_active Abandoned
- 2007-07-26 CN CNA2007800249991A patent/CN101484186A/en active Pending
- 2007-07-26 WO PCT/US2007/074448 patent/WO2008014386A2/en not_active Ceased
-
2008
- 2008-12-09 CR CR10486A patent/CR10486A/en not_active Application Discontinuation
- 2008-12-11 NO NO20085182A patent/NO20085182L/en not_active Application Discontinuation
- 2008-12-11 TN TNP2008000512A patent/TNSN08512A1/en unknown
- 2008-12-15 ZA ZA200810600A patent/ZA200810600B/en unknown
- 2008-12-24 EC EC2008009011A patent/ECSP089011A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2043688A4 (en) | 2009-11-11 |
| KR20090033841A (en) | 2009-04-06 |
| WO2008014386A2 (en) | 2008-01-31 |
| ECSP089011A (en) | 2009-01-30 |
| BRPI0712368A2 (en) | 2012-06-05 |
| MX2008016187A (en) | 2009-01-20 |
| JP2009544736A (en) | 2009-12-17 |
| CA2654911A1 (en) | 2008-01-30 |
| CN101484186A (en) | 2009-07-15 |
| ZA200810600B (en) | 2009-11-25 |
| WO2008014386A3 (en) | 2008-07-03 |
| AU2007279261A1 (en) | 2008-01-31 |
| EA200870603A1 (en) | 2009-06-30 |
| TNSN08512A1 (en) | 2010-04-14 |
| EP2043688A2 (en) | 2009-04-08 |
| CR10486A (en) | 2009-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2011009020A3 (en) | Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers | |
| EA200970953A1 (en) | SPECIFIC INHIBITORS PDGFRβ | |
| NZ598145A (en) | Folate-targeted diagnostics and treatment | |
| EA201100971A1 (en) | DERIVATIVES OF PYRIMIDININDOL FOR THE TREATMENT OF MALIGNANT NORMALIZATION | |
| MY150797A (en) | Combination therapies comprising quinaxoline inhibitors of pi3k-alpha for use in the treatment of cancer | |
| RU2015104537A (en) | METHODS FOR TREATING STOMAL TUMORS OF THE GASTROINTESTINAL TRACT | |
| EA200970932A1 (en) | METHODS OF TREATMENT WITH THE APPLICATION OF PYRIDOPYRIMIDINONOVES INHIBITORS PI3K ALPHA | |
| NO20073651L (en) | Antiangiogenesis therapy of autoimmune disease in patients with failed previous therapy | |
| SG10201906270VA (en) | Combination therapy comprising a b-raf inhibitor and a second inhibitor | |
| EA201100358A1 (en) | DABIGATRAN FOR INTERTEGUAL SURGICAL CATHETERIZATION OF THE HEART | |
| NZ595630A (en) | Methods for preventing and/or treating degenerative disorders of the central nervous system | |
| WO2006017188A3 (en) | Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients | |
| MX2009006574A (en) | LUNG CANCER TREATMENT. | |
| TN2009000136A1 (en) | Sequential combination therapy | |
| CU23798B6 (en) | PHARMACEUTICAL COMBINATION USING ANTIBODIES AGAINST THE RECEIVER OF THE EPIDERMAL GROWTH FACTOR AND IMMUNOSUPPRESSING AGENTS | |
| MX2009003532A (en) | Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin. | |
| WO2008025033A3 (en) | Use of il-27 antagonists for the manufacture of a medicament for the treatment of aplastic anemia | |
| WO2007133796A3 (en) | Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist | |
| MX2011009506A (en) | Mineralocorticoid receptor antagonist and methods of use. | |
| NO20085182L (en) | Treatment of tumors in pediatric patients with antagonists to epidermal growth factor receptor | |
| WO2008002544A3 (en) | Unit dosage forms of temozolomide | |
| CY1112203T1 (en) | ADVERTISING THERAPEUTIC USES OF ADRENergic alfuzosin | |
| PL1964571T3 (en) | Treatment of endothelial dysfunction in diabetic patients | |
| UA56894U (en) | Method for treating chronic diseases in otorhynolaryngology | |
| Defina | Efficacy of nilotinib in a patient relapse after 9 years of imatinib treatment and in stable complete cytogenetic response |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |